524731 JENBURPH

Jenburkt Pharmaceuticals

₹1,162.35
+33.25 (2.94%)
23 November, 2024 15:31 BSE: 524731 NSE: JENBURPHISIN: INE354A01013

Start SIP in Jenburkt Pharmaceuticals

Start SIP

Jenburkt Pharmaceuticals Performance

Day Range

₹ 1,162

52 Week Range

₹ 1,162

Jenburkt Pharmaceuticals Share Price

  • Over 1 Month +18.27%
  • Over 3 Month +5.2%
  • Over 6 Month +48.67%
  • Over 1 Year +70.85%

Jenburkt Pharmaceuticals Key Statistics

Jenburkt Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,162.35
+33.25 (2.94%)
pointer
  • Bullish Moving Average
  • ___
  • 13
  • Bearish Moving Average
  • ___
  • 3
  • 20 Day
  • ₹1,132.23
  • 50 Day
  • ₹1,084.80
  • 100 Day
  • ₹1,026.21
  • 200 Day
  • ₹939.70
  • 20 Day
  • ₹1,107.07
  • 50 Day
  • ₹1,081.62
  • 100 Day
  • ₹1,023.13
  • 200 Day
  • ₹903.08

Jenburkt Pharmaceuticals Resistance and Support

PIVOT
₹1,150.79
Resistance
First Resistance 1,186.57
Second Resistance 1,210.78
Third Resistance 1,246.57
RSI 54.38
MFI 75.28
MACD Single Line 34.90
MACD 36.68
Support
First Support 1,126.57
Second Support 1,090.78
Third Supoort 1,066.57

Jenburkt Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,660 213,492 80.26
Week 3,120 211,006 67.63
1 Month 4,379 320,568 73.2
6 Month 3,577 275,859 77.13

Jenburkt Pharmaceuticals Result Highlights

Jenburkt Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jenburkt Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-11-05 Quarterly Results
2024-07-26 Quarterly Results
2024-05-28 Audited Results & Dividend
2024-02-06 Quarterly Results
2023-11-07 Quarterly Results

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91